AU2003235889A8 - Amide derivatives - Google Patents

Amide derivatives

Info

Publication number
AU2003235889A8
AU2003235889A8 AU2003235889A AU2003235889A AU2003235889A8 AU 2003235889 A8 AU2003235889 A8 AU 2003235889A8 AU 2003235889 A AU2003235889 A AU 2003235889A AU 2003235889 A AU2003235889 A AU 2003235889A AU 2003235889 A8 AU2003235889 A8 AU 2003235889A8
Authority
AU
Australia
Prior art keywords
amide derivatives
amide
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
AU2003235889A
Other versions
AU2003235889A1 (en
Inventor
Toru Kontani
Junji Miyata
Wataru Hamaguchi
Yoji Miyazaki
Osamu Yamamoto
Hiroshi Suzuki
Kenji Sudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RATIONAL DRUG DESIGN LAB
Astellas Pharma Inc
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
RATIONAL DRUG DESIGN LAB
Astellas Pharma Inc
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RATIONAL DRUG DESIGN LAB, Astellas Pharma Inc, Yamanouchi Pharmaceutical Co Ltd filed Critical RATIONAL DRUG DESIGN LAB
Publication of AU2003235889A1 publication Critical patent/AU2003235889A1/en
Publication of AU2003235889A8 publication Critical patent/AU2003235889A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003235889A 2002-05-09 2003-05-08 Amide derivatives Abandoned AU2003235889A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002133416 2002-05-09
JP2002-133416 2002-05-09
PCT/JP2003/005756 WO2003095435A1 (en) 2002-05-09 2003-05-08 Amide derivatives

Publications (2)

Publication Number Publication Date
AU2003235889A1 AU2003235889A1 (en) 2003-11-11
AU2003235889A8 true AU2003235889A8 (en) 2003-11-11

Family

ID=29416669

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003235889A Abandoned AU2003235889A1 (en) 2002-05-09 2003-05-08 Amide derivatives

Country Status (2)

Country Link
AU (1) AU2003235889A1 (en)
WO (1) WO2003095435A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200505894A (en) 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative
EP1844776B1 (en) * 2005-02-02 2010-04-28 Astellas Pharma Inc. Agent for prevention/treatment of disease caused by acyclovir-resistant herpesvirus
JPWO2006082821A1 (en) * 2005-02-02 2008-06-26 アステラス製薬株式会社 Preventive or therapeutic agent for diseases involving herpes virus
EP1844775B1 (en) * 2005-02-02 2010-08-11 Astellas Pharma Inc. Therapeutic agent for the treatment of herpes progenitalis after development of lesions
JP5011739B2 (en) * 2005-02-03 2012-08-29 アステラス製薬株式会社 Pharmaceutical composition containing tetrahydro-2H-thiopyran-4-carboxamide derivative
JPWO2010047295A1 (en) 2008-10-20 2012-03-22 アステラス製薬株式会社 Preventive or therapeutic agent for shingles-related pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199801244T2 (en) * 1995-12-29 1998-12-21 Boehringer Ingelheim Pharmaceuticals, Inc. Herpes kar�� �zellikler ta��yan fenil thiazol t�revleri.
AU3289299A (en) * 1998-02-19 1999-09-06 Tularik Inc. Antiviral agents
WO2000029399A1 (en) * 1998-11-12 2000-05-25 Boehringer Ingelheim (Canada) Ltd. Antiherpes compounds
WO2002038554A1 (en) * 2000-11-10 2002-05-16 Yamanouchi Pharmaceutical Co., Ltd. Amide derivatives

Also Published As

Publication number Publication date
WO2003095435A1 (en) 2003-11-20
AU2003235889A1 (en) 2003-11-11

Similar Documents

Publication Publication Date Title
HK1091830A1 (en) Amide derivatives
AP1850A (en) Spiroindolineplperidine derivatives
EG24050A (en) Heterocylocarboxamide derivatives
AU2003201850A1 (en) N-alkylsulfonyl-substituted amide derivatives
HK1077068A1 (en) Azolidinone-vinyl fused-benzene derivatives
IL166121A0 (en) Indole-3-sulphur derivatives
EP1522540A4 (en) Azaarene derivatives
PL376475A1 (en) N-substituted-2-oxodihydropyridine derivatives
IL165923A0 (en) New quinuclidine amide derivatives
PL373656A1 (en) Substituted amides
ZA200500471B (en) N-biarylmethyl aminocycloalkanecarboxamide derivatives
EP1575901A4 (en) Substituted amides
PL1652843T3 (en) Amide derivatives
ZA200602131B (en) Amide type carboxamide derivatives
GB0329572D0 (en) Amide derivatives
AU2003222659A8 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
GB2403474B (en) Amide derivatives
AU2003235889A8 (en) Amide derivatives
EP1531854A4 (en) O-derivatized nocathiacin derivatives
GB0213488D0 (en) 2-Naphthamide derivatives
AU2003243397A8 (en) Homo-camptothecin derivatives
GB0324789D0 (en) Amide derivatives
AU2003274753A8 (en) Amide compounds
AU2003285777A8 (en) 3-substituted-4-pyrimidone derivatives
GB0221143D0 (en) Dihydropyridinone derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 2, PAGE(S) 613 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME YAMANOUCHI PHARMACEUTICAL CO., LTD., APPLICATION NO. 2003235889, UNDER INID (71) CORRECT THE NAME TO READ YAMANOUCHI PHARMACEUTICAL CO., LTD.; RATIONAL DRUG DESIGN LABORATORIES

TH Corrigenda

Free format text: IN VOL 18, NO 2, PAGE(S) 613 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME RATIONAL DRUG DESIGN LABORATORIES, APPLICATION NO. 2003235889, UNDER INID (43) CORRECT THE PUBLICATION DATE TO READ 24.11.2003